Menin has classically been described as a tumor suppressor, where germline inactivating variants in MEN1 promote the development of tumors in the pituitary, parathyroid, and endocrine pancreas leading to multiple endocrine neoplasia type 1 (MEN1) syndrome [2,3]. Here, MEN1 is linked to multiple endocrine neoplasia type 1.